Question to the Department of Health and Social Care:

To ask Her Majesty's Government whether they have had discussions with any country which is protecting the clinically extremely vulnerable by making pre-exposure prophylaxis (PREP) available to these individuals; and, if so, which countries they have had those discussions with.

The Department’s Antivirals and Therapeutics Taskforce is evaluating the use of pre-exposure prophylaxis and how it could be deployed in the United Kingdom. We have recently engaged with the United States of America on a bilateral basis and discussed with Singapore and Israel during a UK Health Security Agency international forum. These discussions have provided an understanding of the experiences of these countries for the clinical and logistic application of pre-exposure prophylaxis.